All Pharma News
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
03 Apr 2024
Share Share
Equillium Announces Positive Data from the Ph 1b EQUALISE study

Equillium Announces Positive Data from the Ph 1b EQUALISE study
BUSINESSWIRE
01 Apr 2024
Share Share
Equillium delivers new lupus data to Ono`s doorstep

Equillium delivers new lupus data to Ono`s doorstep
Max Bayer FIERCE BIOTECH
01 Apr 2024
Share Share
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
25 Mar 2024
Share Share
Equillium to Present at the H.C. Autoimmune & Inflammatory Disease Conference

Equillium to Present at the H.C. Autoimmune & Inflammatory Disease Conference
BUSINESSWIRE
22 Mar 2024
Share Share
Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102
BUSINESSWIRE
21 Dec 2023
Share Share
Equillium swaps subcutaneous cytokine inhibitor for oral option

Equillium swaps subcutaneous cytokine inhibitor for oral option
James Waldron FIERCE BIOTECH
21 Dec 2023
Share Share
Equillium Presents Positive Data from Phase 1b EQUALISE Study

Equillium Presents Positive Data from Phase 1b EQUALISE Study
BUSINESSWIRE
13 Nov 2023
Share Share
Equillium Reports Third Quarter 2023 Financial Results

Equillium Reports Third Quarter 2023 Financial Results
BUSINESSWIRE
08 Nov 2023
Share Share
Equillium Announces Data from Phase 1b EQUALISE Study Presented

Equillium Announces Data from Phase 1b EQUALISE Study Presented
BUSINESSWIRE
06 Nov 2023
Share Share